Intraventricular Hemorrhage: Clinical Trials

10 trials for Intraventricular Hemorrhage, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 terminated, 2 unknown, 1 active not recruiting. 10 Phase 2, 2 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 210Completed 4, Terminated 2, Unknown 2, Active not recruiting 1, Not yet recruiting 1
Phase 12Completed 1, Unknown 1
Phase 31Terminated 1

Follow Intraventricular Hemorrhage: new trials by email Literature Review of Intraventricular Hemorrhage trials Research Report on Intraventricular Hemorrhage

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Single-dose Prophylactic INdomethacin in Extremely Preterm Infants
Indomethacin, Placebo - Extreme Prematurity, Intraventricular Hemorrhage
Phase 2Not yet recruitingUniversity of British Columbia5002025-11-012025-09-03
A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants
OHB-607 - Bronchopulmonary Dysplasia, Chronic Lung Disease of Prematurity
Phase 2Active not recruitingOHB Neonatology Ltd.2952019-05-092026-08-03
Antibiotic "Dysbiosis" in Preterm Infants
Antibiotic, Gastric fluid, Breast milk - Enterocolitis, Necrotizing, Bacteremia
Phase 2CompletedUniversity of Florida982017-01-162024-06-05
Effects of Delayed Cord Clamp and/or Indomethacin on Preterm Infant Brain Injury
Indomethacin, delay in umbilical cord clamp at birth, placebo infusion - Intraventricular Hemorrhage, Periventricular Leukomalacia
Phase 1 / Phase 2CompletedHong Huang2562014-08-012021-11-23
Intraventricular Tissue Plasminogen Activator (tPA) in the Management of Aneurysmal Subarachnoid Hemorrhage
Tissue Plasminogen Activator, Placebo - Aneurysmal Subarachnoid Hemorrhage, Intraventricular Hemorrhage
Phase 2UnknownUniversity of Calgary122009-10-012010-11-11
Recombinant Erythropoietin for Neuroprotection in Very Preterm Infants
recombinant human erythropoietin (rhEpo), Normal saline - Infant, Premature, Leukomalacia, Periventricular
Phase 1 / Phase 2UnknownChina Medical University Hospital1002009-08-012009-05-29
Inhaled Nitric Oxide and Neuroprotection in Premature Infants
inhaled nitric oxide, oxygen - Prematurity, Bronchopulmonary Dysplasia
Phase 2 / Phase 3TerminatedUniversity of Chicago2732008-05-012024-10-17
Protective Effects of Delayed Cord Clamping in Very Low Birth Weight (VLBW) Infants
delayed umbilical cord clamping, Immediate cord clamping - Intraventricular Hemorrhage, Sepsis
Phase 2CompletedUniversity of Rhode Island2112008-02-012015-05-27
High-Dose Erythropoietin in Extremely Premature Infants to Prevent/Attenuate Brain Injury: A Phase II Study
Erythropoietin, Saline placebo - Infant, Premature, Erythropoietin
Phase 2TerminatedAtlantic Health System222007-07-012013-07-30
Clinical Trial on Treatment of Intraventricular Hemorrhage
tissue plasminogen activator, rt-PA (thrombolytic) (Cathflo) - Intraventricular Hemorrhage
Phase 2CompletedJohns Hopkins University522004-02-012017-12-11

Narrower conditions

Leukomalacia, Periventricular (5)  ·  Bronchopulmonary Dysplasia (3)  ·  Premature Birth (3)  ·  Brain Injuries (2)  ·  Retinopathy of Prematurity (2)  ·  Bacteremia (1)  ·  Enterocolitis, Necrotizing (1)  ·  Sepsis (1)  ·  Subarachnoid Hemorrhage (1)

Broader conditions

Brain Diseases (6)  ·  Cardiovascular Diseases (6)  ·  Central Nervous System Diseases (6)  ·  Cerebrovascular Disorders (6)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (6)  ·  Infant, Newborn, Diseases (6)  ·  Infant, Premature, Diseases (6)  ·  Nervous System Diseases (6)  ·  Vascular Diseases (6)  ·  Encephalomalacia (5)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Lung Diseases (3)  ·  Lung Injury (3)  ·  Obstetric Labor Complications (3)  ·  Obstetric Labor, Premature (3)

Interventions

Indomethacin (2)  ·  Saline Solution (2)  ·  Tissue Plasminogen Activator (2)  ·  Ampicillin (1)  ·  Anti-Bacterial Agents (1)  ·  Cefotaxime (1)  ·  Erythropoietin (1)  ·  Fibrinolytic Agents (1)  ·  Gentamicins (1)  ·  Insulin-Like Growth Factor I (1)  ·  Milk, Human (1)  ·  Oxygen (1)  ·  Umbilical Cord Clamping (1)

Sponsors

Atlantic Health System (1)  ·  China Medical University Hospital (1)  ·  Hong Huang (1)  ·  Johns Hopkins University (1)  ·  OHB Neonatology Ltd. (1)  ·  University of British Columbia (1)  ·  University of Calgary (1)  ·  University of Chicago (1)  ·  University of Florida (1)  ·  University of Rhode Island (1)

Countries

United States (8)  ·  Canada (4)  ·  Australia (2)  ·  Germany (2)  ·  United Kingdom (2)  ·  Finland (1)  ·  Ireland (1)  ·  Italy (1)  ·  Japan (1)  ·  Netherlands (1)  ·  Portugal (1)  ·  Spain (1)  ·  Sweden (1)  ·  Taiwan (1)

Top investigators

Andreas Kramer, MD (1)  ·  Bai-Horng Su, MD, PhD (1)  ·  Daniel F Hanley, MD (1)  ·  Hong Huang, MD-PhD (1)  ·  John Bauer, PhD (1)  ·  Josef Neu, MD (1)  ·  Judith S Mercer, PhD, CNM (1)  ·  Michael D. Schreiber, M.D. (1)  ·  Souvik Mitra, MD, PhD (1)  ·  Vicki Whitehead, RN (1)

Results publications

PMID 21940973, PMID 22331336, PMID 22382155, PMID 22474059, PMID 23370203, PMID 23463422, PMID 26228884, PMID 26547399, PMID 29954605, PMID 33479274, PMID 35681088, PMID 37308133, PMID 39373498, PMID 41786363

NIH funding

2018 (1), R01HD070792 (1), R01NR010015 (1), R21HD088005 (1)